Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$3.41 - $8.95 $951 - $2,497
-279 Reduced 69.92%
120 $1,000
Q1 2022

May 16, 2022

BUY
$7.78 - $15.31 $2,652 - $5,220
341 Added 587.93%
399 $3,000
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $216 - $285
-12 Reduced 17.14%
58 $1,000
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $1,420 - $1,927
70 New
70 $2,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $106M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.